Article Text
PDFReviews
Autoantibody testing in encephalopathies
Statistics from Altmetric.com
Footnotes
-
Competing interests AV and the Department of Clinical Neurology in Oxford receive royalties and payments for antibody assays. AV is the inventor on patent application WO/2010/046716 entitled ‘Neurological Autoimmune Disorders’. The patent has been licensed to Euroimmun AG for the development of assays for LGI1 and other VGKC-complex antibodies. AV acts as a paid consultant for Athena Diagnostics and is employed by Oxford University and University College London. AV and SRI may receive royalties for testing of VGKC-complex antibodies.
-
Provenance and peer review Commissioined by Charles Warlow; this paper was reviewed by Neil Scolding.
Read the full text or download the PDF:
Other content recommended for you
- Republished review: Autoantibody testing in encephalopathies
- Emerging psychiatric syndromes associated with antivoltage-gated potassium channel complex antibodies
- Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition
- Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre
- Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies
- Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia
- Paraneoplastic encephalitis: clinically based approach on diagnosis and management
- Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens
- Delayed LGI1 seropositivity in voltage-gated potassium channel (VGKC)-complex antibody limbic encephalitis
- Automated volumetry of the mesiotemporal structures in antibody-associated limbic encephalitis